162 related articles for article (PubMed ID: 11156711)
21. Loss of CD10 (neutral endopeptidase) is a frequent and early event in human prostate cancer.
Freedland SJ; Seligson DB; Liu AY; Pantuck AJ; Paik SH; Horvath S; Wieder JA; Zisman A; Nguyen D; Tso CL; Palotie AV; Belldegrun AS
Prostate; 2003 Apr; 55(1):71-80. PubMed ID: 12640663
[TBL] [Abstract][Full Text] [Related]
22. Gonadotropin-releasing hormone receptor expression in the human prostate.
Tieva A ; Stattin P; Wikström P; Bergh A; Damber JE
Prostate; 2001 Jun; 47(4):276-84. PubMed ID: 11398175
[TBL] [Abstract][Full Text] [Related]
23. Expression and localization of GLUT1 and GLUT12 in prostate carcinoma.
Chandler JD; Williams ED; Slavin JL; Best JD; Rogers S
Cancer; 2003 Apr; 97(8):2035-42. PubMed ID: 12673735
[TBL] [Abstract][Full Text] [Related]
24. Detection of metastatic breast cancer by beta-hCG polymerase chain reaction.
Hoon DS; Sarantou T; Doi F; Chi DD; Kuo C; Conrad AJ; Schmid P; Turner R; Guiliano A
Int J Cancer; 1996 Oct; 69(5):369-74. PubMed ID: 8900369
[TBL] [Abstract][Full Text] [Related]
25. Comparison of immunohistochemistry with reverse transcription-PCR for the detection of micrometastatic prostate cancer in lymph nodes.
Shariat SF; Roudier MP; Wilcox GE; Kattan MW; Scardino PT; Vessella RL; Erdamar S; Nguyen C; Wheeler TM; Slawin KM
Cancer Res; 2003 Aug; 63(15):4662-70. PubMed ID: 12907647
[TBL] [Abstract][Full Text] [Related]
26. Surgery-related shedding of breast cancer cells as determined by RT-PCR assay.
Hu XC; Loo WT; Chow LW
J Surg Oncol; 2003 Apr; 82(4):228-32; discussion 233. PubMed ID: 12672005
[TBL] [Abstract][Full Text] [Related]
27. Assessment of messenger RNA of beta 1-->4-N-acetylgalactosaminyl-transferase as a molecular marker for metastatic melanoma.
Kuo CT; Bostick PJ; Irie RF; Morton DL; Conrad AJ; Hoon DS
Clin Cancer Res; 1998 Feb; 4(2):411-8. PubMed ID: 9516930
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of human chorionic gonadotropin beta-subunit modulates the mitogenic effect of c-myc in human prostate cancer cells.
Devi GR; Oldenkamp JR; London CA; Iversen PL
Prostate; 2002 Nov; 53(3):200-10. PubMed ID: 12386920
[TBL] [Abstract][Full Text] [Related]
29. A novel human prostate-specific gene-1 (HPG-1): molecular cloning, sequencing, and its potential involvement in prostate carcinogenesis.
Herness EA; Naz RK
Cancer Res; 2003 Jan; 63(2):329-36. PubMed ID: 12543784
[TBL] [Abstract][Full Text] [Related]
30. Heterogeneous expression of MAGE-A genes in occult disseminated tumor cells: a novel multimarker reverse transcription-polymerase chain reaction for diagnosis of micrometastatic disease.
Kufer P; Zippelius A; Lutterbüse R; Mecklenburg I; Enzmann T; Montag A; Weckermann D; Passlick B; Prang N; Reichardt P; Dugas M; Köllermann MW; Pantel K; Riethmüller G
Cancer Res; 2002 Jan; 62(1):251-61. PubMed ID: 11782385
[TBL] [Abstract][Full Text] [Related]
31. [Expression and implication of cyclooxygenase-2 mRNA in prostate cancer].
Yang MS; Xia SJ; Liu HT; Sun XW; Han BM; Wu JT; Lu J; Ling GM; Tang XD
Zhonghua Nan Ke Xue; 2006 Feb; 12(2):159-61. PubMed ID: 16519157
[TBL] [Abstract][Full Text] [Related]
32. Down-regulation of prostasin serine protease: a potential invasion suppressor in prostate cancer.
Chen LM; Hodge GB; Guarda LA; Welch JL; Greenberg NM; Chai KX
Prostate; 2001 Jul; 48(2):93-103. PubMed ID: 11433419
[TBL] [Abstract][Full Text] [Related]
33. Preoperative blood reverse transcriptase-PCR assays for prostate-specific antigen and human glandular kallikrein for prediction of prostate cancer progression after radical prostatectomy.
Shariat SF; Gottenger E; Nguyen C; Song W; Kattan MW; Andenoro J; Wheeler TM; Spencer DM; Slawin KM
Cancer Res; 2002 Oct; 62(20):5974-9. PubMed ID: 12384565
[TBL] [Abstract][Full Text] [Related]
34. [In vitro detection of prostate cancer circulating cells by immunocytochemistry, flow cytometry and RT-PCR PSA].
de la Taille A; Muscatelli B; Colombel M; Jouault H; Amsellem S; Mazeman E; Abbou CC; Chopin D
Prog Urol; 1998 Dec; 8(6):1058-64. PubMed ID: 9894270
[TBL] [Abstract][Full Text] [Related]
35. Detection of germ cell tumor cells in apheresis products using polymerase chain reaction.
Fan Y; Einhorn L; Saxman S; Katz B; Abonour R; Cornetta K
Clin Cancer Res; 1998 Jan; 4(1):93-8. PubMed ID: 9516957
[TBL] [Abstract][Full Text] [Related]
36. [Expression and clinical significance of antiapoptosis gene XIAP in prostate cancer].
Liu J; Li M; Xia S
Zhonghua Nan Ke Xue; 2004 Nov; 10(11):832-5. PubMed ID: 15595685
[TBL] [Abstract][Full Text] [Related]
37. mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients.
Marchetti A; Buttitta F; Bertacca G; Zavaglia K; Bevilacqua G; Angelucci D; Viacava P; Naccarato A; Bonadio A; Barassi F; Felicioni L; Salvatore S; Mucilli F
J Pathol; 2001 Sep; 195(2):186-90. PubMed ID: 11592097
[TBL] [Abstract][Full Text] [Related]
38. The expression of the human chorionic gonadotropin beta subunit gene depends on negative control.
Chen YH; Chen TM; Hsieh CY
Cell Biochem Funct; 1996 Dec; 14(4):297-301. PubMed ID: 8952049
[TBL] [Abstract][Full Text] [Related]
39. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
[TBL] [Abstract][Full Text] [Related]
40. Prostate-specific antigen mRNA and protein levels in laser microdissected cells of human prostate measured by real-time reverse transcriptase-quantitative polymerase chain reaction and immuno-quantitative polymerase chain reaction.
Pinzani P; Lind K; Malentacchi F; Nesi G; Salvianti F; Villari D; Kubista M; Pazzagli M; Orlando C
Hum Pathol; 2008 Oct; 39(10):1474-82. PubMed ID: 18619642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
